Circulating granzyme A levels have previously been shown to be elevated in patients suffering from infections with dengue [105], EBV, HIV-1 [108], primary CMV [109], malaria [142], and bacteria [106,143], and also in rheumatoid arthritis patients [110]. This evidence concerns the gene GZMA and infection.